AI assistant
Sending…
Chemours Co — Director's Dealing 2021
Jul 3, 2021
31561_dirs_2021-07-02_daa92c9f-28c2-4a85-8e7b-e553c0fe0cc0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2021-07-01
Reporting Person: Newman Mark (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-01 | Common Stock | A | 3948 | — | Acquired | 145377.484 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-01 | Stock Option (Right to Buy) | $35.46 | A | 34696 | Acquired | 2031-03-01 | Common Stock (34696) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2480 | Indirect |
Footnotes
F1: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022.
F2: Includes directly owned shares, stock units and dividend equivalent units.
F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2022.
More from Chemours Co
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3